@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix owl: . @prefix dc: . @prefix xsd: . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-MCXK29NN-K skos:prefLabel "Antifongiques"@fr, "Antifungal Agents"@en ; a mesh:Descriptor, skos:Concept . jvr:-M8BW45MT-J skos:prefLabel "Cytochrome P-450 CYP2C19 Inhibitors"@en, "Inhibiteurs du cytochrome P-450 CYP2C19"@fr ; a mesh:Descriptor, skos:Concept . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-DV1BPDDG-0 skos:prefLabel "Inhibiteurs de la 14-alpha déméthylase"@fr, "14-alpha Demethylase Inhibitors"@en ; a mesh:Descriptor, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-XJX8X9V2-X skos:prefLabel "Cytochrome P-450 CYP2C9 Inhibitors"@en, "Inhibiteurs du cytochrome P-450 CYP2C9"@fr ; a mesh:Descriptor, skos:Concept . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-PWZCXDF8-3 skos:prefLabel "Triazoles"@fr, "Triazoles"@en ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-SB41HZTX-L . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-SB41HZTX-L skos:hiddenLabel "Flucobeta"@en, "UK-49858"@fr, "UK-49858"@en, "Fluconazol von ct"@en, "Fungata"@en, "Fluconazol AbZ"@en, "Béagyne"@en, "Fluc Hexal"@en, "Oxifungol"@en, "Lavisa"@en, "Fluconazol-Isis"@en, "Zonal"@en, "Fluconazol Stada"@en, "Flunazul"@en, "Diflucan"@en, "Fluconazol AL"@en, "UK49858"@fr, "Neofomiral"@en, "Loitin"@en, "Fluconazol-ratiopharm"@en, "Triflucan"@en, "Solacap"@en, "Apo-Fluconazole"@en, "FlucoLich"@en ; mesh:allowableQualifier jvr:-FWD2BGQ0-9, jvr:-THHNVC7V-3, jvr:-M63HSDM7-1, jvr:-D0F21513-5, jvr:-NB0XHT3S-N, jvr:-S0CS1X5R-5, jvr:-T9HQD7ST-J, jvr:-WK5F724J-1, jvr:-W6SQV79N-S, jvr:-NHL3D2X0-S, jvr:-SBNWSM1T-R, jvr:-NFTHND7Q-8, jvr:-HQRFT0C6-B, jvr:-BT300B3G-Q, jvr:-L6C0XPHT-4, jvr:-G4R176S9-J, jvr:-NKM836P1-M, jvr:-CB30NGKB-3, jvr:-Q3979798-W, jvr:-R0ZCQ8X6-J, jvr:-R3QWLHRG-V, jvr:-H7K65Q8S-Z, jvr:-TJHVZCRZ-0, jvr:-G30ZJ446-J, jvr:-XV06LPML-W ; skos:definition "Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS."@en ; owl:sameAs ; skos:altLabel "1H-1,2,4-Triazole-1-ethanol, alpha-(2,4-difluorophenyl)-alpha-(1H-1,2,4-triazol-1-ylmethyl)-"@fr, "1H-1,2,4-Triazole-1-ethanol, alpha-(2,4-difluorophenyl)-alpha-(1H-1,2,4-triazol-1-ylmethyl)-"@en, "86386-73-4 (Fluconazole)"@fr, "86386-73-4 (Fluconazole)"@en, "8VZV102JFY"@fr, "8VZV102JFY"@en ; mesh:pharmacologicalAction jvr:-M8BW45MT-J, jvr:-MCXK29NN-K, jvr:-DV1BPDDG-0, jvr:-XJX8X9V2-X ; skos:broader jvr:-PWZCXDF8-3 ; dc:established "1990-01-01"^^xsd:date ; dc:created "1989-05-15"^^xsd:date ; skos:prefLabel "Fluconazole"@fr, "Fluconazole"@en ; dc:modified "2017-01-17"^^xsd:date ; skos:inScheme jvr: ; a skos:Concept, mesh:Descriptor . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept .